Cetera Investment Advisers Zomedica Corp. Transaction History
Cetera Investment Advisers
- $45.9 Billion
- Q4 2024
A detailed history of Cetera Investment Advisers transactions in Zomedica Corp. stock. As of the latest transaction made, Cetera Investment Advisers holds 36,700 shares of ZOM stock, worth $4,404. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,700
Previous 258,001
85.78%
Holding current value
$4,404
Previous $36,000
88.89%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ZOM
# of Institutions
93Shares Held
91.3MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA48.1MShares$5.77 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA9.89MShares$1.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.86MShares$1.18 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.12MShares$494,4770.0% of portfolio
-
Ubs Group Ag3.94MShares$472,2520.0% of portfolio
About Zomedica Corp.
- Ticker ZOM
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 979,950,016
- Market Cap $118M
- Description
- Zomedica Corp., a veterinary health company, focuses on the unmet needs of clinical veterinarians by developing products for companion animals. The company engages in the development and commercialization of TRUFORMA platform, which offers point-of-care diagnostic products for disease states in dogs and cats; and PulseVet, provides for treatment...